Mankind Pharma to integrate Bharat Serums & Vaccines business

Mankind Pharma Limited's Board of Directors has approved the integration of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), through a voluntary liquidation process. BSVL's business will be consolidated into Mankind Pharma on a going concern basis, with Appian Properties Private Limited, a 4% shareholder, to receive cash proportionate to its stake. This move aims to drive operational efficiencies, improve organizational execution, enhance cash management, and reduce compliance requirements. The voluntary liquidation will be managed by a liquidator appointed by BSVL, adhering to the Insolvency and Bankruptcy Code.